ELVN
Enliven Therapeutics Inc.
$19.92
+$0.96(+5.06%)
40
Overall
--
Value
40
Tech
--
Quality
Market Cap
$1.12B
Volume
423.26K
52W Range
$13.30 - $30.03
Target Price
$41.13
Key Metrics Overview
| Market Cap | $1.12B | P/E Ratio | N/A |
| 52W High | $30.03 | 52W Low | $13.30 |
| Div Yield | N/A | Payout Ratio | 0.0% |
| EPS Growth 3Y | N/A | 52W Position | 39.6% |
| Overall Score | 40 | Value Score | -- |
| Quality Score | -- | Technical Score | 40 |
Growth Analysis
| EPS Current Est | $-1.95 | EPS Next Est | $-2.19 |
| EPS Growth Est | N/A | DPS Growth 3Y | N/A |
Revenue (5Y)
No data available
EBITDA (5Y)
No data available
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ELVN | $19.92 | +5.1% | 423.26K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Enliven Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW